QCOM · Qualcomm Inc/De · Insider Trading

Represents Deferred Stock Units (DSUs) issued in lieu of payment of cash retainer fees. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock in accordance with the grant agreement on the earlier of (1) separation from service, (2) death, (3) disability, or (4) a change in control.

Represents Deferred Stock Units (DSUs) issued in lieu of payment of cash retainer fees. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025.

Shares held by the reporting person's family trust, for which the reporting person and his spouse are trustees. The reporting person and members of his immediate family are the sole beneficiaries of the trust.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2025.

Shares held by the reporting person's family trust, for which the reporting person and his spouse are trustees. The reporting person and members of his immediate family are the sole beneficiaries of the trust.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $179.4675 to $180.2200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $183.3800 to $184.2450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $177.3150 to $178.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $184.3150 to $185.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $178.4400 to $179.0125. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $180.4400 to $181.2800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $182.3525 to $183.2100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $181.3550 to $182.3100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2025.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028.

Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2024 and ending on November 20, 2026.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2027.

Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2025 and ending on November 20, 2027.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Each Restricted Stock Unit is the economic equivalent of one share of Qualcomm common stock and converts on a one-for-one basis.

The Restricted Stock Units (and allocable dividend equivalents) vest in equal quarterly amounts beginning on February 20, 2026 and ending on November 20, 2028.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $161.1150 to $162.1000. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $164.1350 to $165.0850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $163.1150 to $164.0600. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $165.1175 to $165.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $162.1350 to $163.1075. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025.

Shares held by the reporting person's family trust, for which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the sole beneficiaries of the trust.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $180.7950 to $181.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $181.7600 to $182.7100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $178.7550 to $179.6450. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $185.7800 to $186.7250. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $179.7700 to $180.7350. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $182.7650 to $183.6850. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $177.7400 to $178.7200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $183.7600 to $184.6800. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $186.9550 to $187.5650. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $189.2850 to $189.6575. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

Represents Deferred Stock Units (DSUs) issued in lieu of payment of cash retainer fees. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. If an election is made to settle the units partially in cash, such partial cash settlement will be reported on a subsequent Form 4 (if applicable) as a disposition to the Issuer on the settlement date.

Represents Deferred Stock Units (DSUs) issued in lieu of payment of cash retainer fees. Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock in accordance with the grant agreement on the earlier of (1) separation from service, (2) death, (3) disability, or (4) a change in control.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $194.1400 to $195.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $200.1450 to $201.0050. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $199.1700 to $200.1300. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $201.1800 to $202.1100. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

The sale prices for this transaction ranged from $193.1400 to $194.1200. The filer hereby agrees to provide, upon request, full information regarding the number of shares sold at each separate price.